Stock listing

NYSE:REF Refac Optical Group Stock

Follow Refac Optical Group into a list and get an email when it puts out news.

Delisted NYSE:REF no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NYSE:REF
Asset type
Stock
Exchange
NYSE
Currency
USD

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 5, 2026 · After close+7.1%
Quarter to Jun 30, 2026Sep 10, 2026 · After close+6.7%

Open Events

Cap table

Built by 6ix from Refac Optical Group’s releases · as of Sep 8, 2026

Common shares
59,079,320
Fully diluted
59,079,320

Fully diluted

LineSharesAs of
Common shares59,079,320Sep 8, 2026

Share count over time

CountShares
Sep 8, 202659,079,320

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Dennison T Veru
Other companies: Chemomab Therapeutics Ltd. (Director · Jan 1, 2020 – Jan 1, 2020 · Past); Brickell Biotech Inc (Director · Aug 31, 2019 – May 17, 2022 · Past)
Director · Mar 6, 2006 – Mar 6, 2006 · Past
Mark N Kaplan
Other companies: Volt Information Sciences Inc (Director · Apr 5, 2007 – Aug 12, 2014 · Past); Autoweb Inc (Director · Mar 21, 2006 – Aug 31, 2022 · Past)
Director · Jun 26, 2006 – Apr 25, 2007 · Past
Clark A Johnson
Other companies: PSS World Medical Inc (Director · Aug 24, 2006 – Jan 5, 2007 · Past)
Director · Mar 6, 2006 – Apr 26, 2007 · Past
James T JahnkeDirector · Apr 27, 2007 – Apr 27, 2007 · Past
J David PiersonPresident and CEO, Director · Apr 27, 2007 – Apr 27, 2007 · Past
Melvin MeskinDirector · Mar 6, 2006 – Jun 26, 2006 · Past

Open People

Log in to ask 6ix AI your own questions about Refac Optical Group.